The report covers forecast and analysis for the heart pump device market on a global and regional level. The study provides historical data for2016 and 2017along with a forecast from 2018 to 2024based on the revenue (USD Million). The study includes drivers and restraints for the heart pump device market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the heart pump device market on a global level.
In order to give the users of this report a comprehensive view on the heart pump device market, we have included a competitive landscape and an analysis of the Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment, type segment, and therapy segment are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launches, agreements, partnerships, collaborations & joint ventures,research& development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers a price trend analysis and product portfolio of various companies according to the region.
The study provides a decisive view on the heart pump device market by segmenting the market based on product, type, therapy, and by geography. Based on the product, the market is segmented into ventricular assist devices, intra-aortic balloon pumps, and total artificial heart. The ventricular assist devices segment is further sub-segmented into left ventricular assist devices, right ventricular assist devices, bi-ventricular assist devices, and percutaneous ventricular assist devices. On the basis of type, the market is segmented into implantable heart pump devices and extracorporeal heart pump devices. The therapy segment is divided intoBridge-To-Candidacy (BTC), Bridge-To-Transplant (BTT), Destination Therapy (DT), and other therapies. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America,and Middle East and Africa with its further division into major countries including the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific,Brazil, Rest of Latin America, GCC Countries, South Africa,and Rest of the Middle East and Africa. This segmentation includes demand for heart pump device market based on individual product, type, and therapy in all regions and countries.
The report also includes detailed profiles of end players such as Abbott Laboratories, Abiomed, Medtronic, Getinge, Syncardia Systems, Teleflex, Reliantheart, Terumo, Berlin Heart, Jarvik Heart, Cardiacassist, and Fresenius Medical Care.
This report segments the global heart pump device market as follows:
Global Heart Pump Device Market: Product Segment Analysis
- Ventricular Assist Devices
- Left Ventricular Assist Devices
- Right Ventricular Assist Devices
- Bi-Ventricular Assist Devices
- Percutaneous Ventricular Assist Devices
- Intra-Aortic Balloon Pumps
- Total Artificial Heart
Global Heart Pump Device Market: Type Segment Analysis
- Implantable Heart Pump Devices
- Extracorporeal Heart Pump Devices
Global Heart Pump Device Market: Therapy Segment Analysis
- Bridge-To-Candidacy (BTC)
- Bridge-To-Transplant (BTT)
- Destination Therapy (DT)
- Other Therapies
Global Heart Pump Device Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
